• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性柯萨奇病毒B3心肌炎小鼠模型中的电生理改变

Electrophysiological alterations in a murine model of chronic coxsackievirus B3 myocarditis.

作者信息

Kaese Sven, Larbig Robert, Rohrbeck Matthias, Frommeyer Gerrit, Dechering Dirk, Olligs Jan, Schönhofer-Merl Sabine, Wessely Rainer, Klingel Karin, Seebohm Guiscard, Eckardt Lars

机构信息

Division of Electrophysiology, Department of Cardiovascular Medicine, University of Münster, Münster, Germany.

The IfGH-Myocellular Electrophysiology, Department of Cardiovascular Medicine, University of Münster, Münster, Germany.

出版信息

PLoS One. 2017 Jun 23;12(6):e0180029. doi: 10.1371/journal.pone.0180029. eCollection 2017.

DOI:10.1371/journal.pone.0180029
PMID:28644868
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5482483/
Abstract

INTRODUCTION

Coxsackievirus B3 (CVB3) is known to induce acute and chronic myocarditis. Most infections are clinically unapparent but some patients suffer from ventricular arrhythmias (VA) and sudden cardiac death (SCD). Studies showed that acute CVB3 infection may cause impaired function of cardiac ion channels, creating a proarrhythmic substrate. However, it is unknown whether low level CVB3+ expression in myocytes may cause altered cardiac electrophysiology leading to VA.

METHODS

Cellular electrophysiology was used to analyze cellular action potentials (APs) and occurrence of afterdepolarizations from isolated cardiomyocytes of wildtype (WT) and transgenic CVB3ΔVP0 (CVB3+) mice. Further, we studied surface ECGs, monophasic APs, ventricular effective refractory period (VERP) and inducibility of VAs in Langendorff-perfused whole hearts. All used cardiomyocytes and whole hearts originated from male mice.

RESULTS

Cellular action potential duration (APD) in WT and CVB3+ myocytes was unchanged. No difference in mean occurrence or amplitude of afterdepolarizations in WT and CVB3+ myocytes was found. Interestingly, resting membrane potential in CVB3+ myocytes was significantly hyperpolarized (WT: -90.0±2.2 mV, n = 7; CVB3+: -114.1±3.0 mV, n = 14; p<0.005). Consistently, in Langendorff-perfused hearts, APDs were also not different between WT and CVB3+ whole hearts. Within both groups, we found a heart rate dependent shortening of ADP90 with increasing heart rate in Langendorff-perfused hearts. VERP was significantly prolonged in CVB3+ hearts compared to WT (WT: 36.0±2.7 ms, n = 5; CVB3+: 47.0±2.0 ms, n = 7; p = 0.018). Resting heart rate (HR) in Langendorff-perfused hearts was not significantly different between both genotypes. Electrical pacing protocols induced no VA in WT and CVB3+ hearts.

CONCLUSION

In CVB3+ mice, prolonged ventricular refractoriness and hyperpolarized resting membrane potentials in presence of unchanged APD were observed, suggesting that low level CVB3 expression does not promote VA by altered cardiac electrophysiology in this type of chronic myocarditis. These findings may suggest that other mechanisms such as chronic myocardial inflammation or fibrosis may account for arrhythmias observed in patients with chronic enteroviral myocarditis.

摘要

引言

已知柯萨奇病毒B3(CVB3)可诱发急性和慢性心肌炎。大多数感染在临床上并无明显症状,但有些患者会出现室性心律失常(VA)和心源性猝死(SCD)。研究表明,急性CVB3感染可能导致心脏离子通道功能受损,从而形成促心律失常基质。然而,心肌细胞中低水平的CVB3+表达是否会导致心脏电生理改变进而引发VA尚不清楚。

方法

利用细胞电生理学分析野生型(WT)和转基因CVB3ΔVP0(CVB3+)小鼠分离的心肌细胞的细胞动作电位(AP)和后去极化的发生情况。此外,我们研究了Langendorff灌注全心脏的体表心电图、单相动作电位、心室有效不应期(VERP)和VA的诱发性。所有使用的心肌细胞和全心脏均来自雄性小鼠。

结果

WT和CVB3+心肌细胞的细胞动作电位持续时间(APD)未发生变化。WT和CVB3+心肌细胞后去极化的平均发生率或幅度没有差异。有趣的是,CVB3+心肌细胞的静息膜电位显著超极化(WT:-90.0±2.2 mV,n = 7;CVB3+:-114.1±3.0 mV,n = 14;p<0.005)。同样,在Langendorff灌注心脏中,WT和CVB3+全心脏的APD也没有差异。在两组中,我们发现Langendorff灌注心脏中ADP90随心率增加而呈心率依赖性缩短。与WT相比,CVB3+心脏的VERP显著延长(WT:36.0±2.7 ms,n = 5;CVB3+:47.0±2.0 ms,n = 7;p = 0.018)。Langendorff灌注心脏中两种基因型的静息心率(HR)无显著差异。电起搏方案在WT和CVB3+心脏中均未诱发VA。

结论

在CVB3+小鼠中,观察到心室不应期延长和静息膜电位超极化,而APD未改变,这表明在这种类型的慢性心肌炎中,低水平的CVB3表达不会通过改变心脏电生理来促进VA。这些发现可能表明,其他机制,如慢性心肌炎症或纤维化,可能是慢性肠道病毒心肌炎患者心律失常的原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0071/5482483/a9756e7921bf/pone.0180029.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0071/5482483/2a5b4a9d5988/pone.0180029.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0071/5482483/1e2c223aba10/pone.0180029.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0071/5482483/fe3fdb1ae20e/pone.0180029.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0071/5482483/c7bb2e4a9125/pone.0180029.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0071/5482483/a9756e7921bf/pone.0180029.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0071/5482483/2a5b4a9d5988/pone.0180029.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0071/5482483/1e2c223aba10/pone.0180029.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0071/5482483/fe3fdb1ae20e/pone.0180029.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0071/5482483/c7bb2e4a9125/pone.0180029.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0071/5482483/a9756e7921bf/pone.0180029.g005.jpg

相似文献

1
Electrophysiological alterations in a murine model of chronic coxsackievirus B3 myocarditis.慢性柯萨奇病毒B3心肌炎小鼠模型中的电生理改变
PLoS One. 2017 Jun 23;12(6):e0180029. doi: 10.1371/journal.pone.0180029. eCollection 2017.
2
Involvement of Endoplasmic Reticulum Stress-Mediated C/EBP Homologous Protein Activation in Coxsackievirus B3-Induced Acute Viral Myocarditis.内质网应激介导的 C/EBP 同源蛋白激活在柯萨奇病毒 B3 诱导的急性病毒性心肌炎中的作用。
Circ Heart Fail. 2015 Jul;8(4):809-18. doi: 10.1161/CIRCHEARTFAILURE.114.001244. Epub 2015 May 18.
3
Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy.基质金属蛋白酶-2 降低趋化因子 MCP-3 的降解,加重实验性病毒性心肌病中的心肌炎症。
Circulation. 2011 Nov 8;124(19):2082-93. doi: 10.1161/CIRCULATIONAHA.111.035964. Epub 2011 Oct 10.
4
Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses.脂联素通过抑制急性抗病毒免疫反应促进柯萨奇病毒 B3 心肌炎。
Basic Res Cardiol. 2014 May;109(3):408. doi: 10.1007/s00395-014-0408-y. Epub 2014 Apr 2.
5
Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.早期用可溶性柯萨奇病毒-腺病毒受体抑制剂治疗柯萨奇病毒 B3 感染动物可抑制慢性柯萨奇病毒 B3 心肌病的发展。
Circ Heart Fail. 2019 Nov;12(11):e005250. doi: 10.1161/CIRCHEARTFAILURE.119.005250. Epub 2019 Nov 13.
6
Astragaloside IV reduces cardiomyocyte apoptosis in a murine model of coxsackievirus B3-induced viral myocarditis.黄芪甲苷可减少柯萨奇病毒 B3 诱导的病毒性心肌炎小鼠模型中心肌细胞凋亡。
Exp Anim. 2019 Nov 6;68(4):549-558. doi: 10.1538/expanim.19-0037. Epub 2019 Jun 26.
7
CX3CR1 knockout aggravates Coxsackievirus B3-induced myocarditis.CX3CR1基因敲除加重柯萨奇病毒B3诱导的心肌炎。
PLoS One. 2017 Aug 11;12(8):e0182643. doi: 10.1371/journal.pone.0182643. eCollection 2017.
8
Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3-Induced Myocarditis.损伤相关分子模式S100A8和S100A9在柯萨奇病毒B3诱导的心肌炎中的致病作用
Circ Heart Fail. 2017 Nov;10(11). doi: 10.1161/CIRCHEARTFAILURE.117.004125.
9
Development of a new mouse model for coxsackievirus-induced myocarditis by attenuating coxsackievirus B3 virulence in the pancreas.通过削弱胰腺中柯萨奇病毒 B3 的毒力来开发一种新的柯萨奇病毒诱导心肌炎的小鼠模型。
Cardiovasc Res. 2020 Aug 1;116(10):1756-1766. doi: 10.1093/cvr/cvz259.
10
In Vitro Model Systems of Coxsackievirus B3-Induced Myocarditis: Comparison of Commonly Used Cell Lines and Characterization of CVB3-Infected iCell Cardiomyocytes.体外柯萨奇病毒 B3 诱导心肌炎模型系统:常用细胞系的比较及 iCell 心肌细胞感染 CVB3 的特征。
Viruses. 2021 Sep 14;13(9):1835. doi: 10.3390/v13091835.

引用本文的文献

1
New drug discovery of cardiac anti-arrhythmic drugs: insights in animal models.新型抗心律失常药物的发现:动物模型的研究进展。
Sci Rep. 2023 Sep 29;13(1):16420. doi: 10.1038/s41598-023-41942-4.
2
Pathophysiological Mechanisms of Cardiac Dysfunction in Transgenic Mice with Viral Myocarditis.病毒性心肌炎转基因小鼠心脏功能障碍的病理生理机制。
Cells. 2023 Feb 8;12(4):550. doi: 10.3390/cells12040550.
3
Animal Models to Study Cardiac Arrhythmias.研究心脏心律失常的动物模型。

本文引用的文献

1
Computational Representations of Myocardial Infarct Scars and Implications for Arrhythmogenesis.心肌梗死瘢痕的计算表征及其对心律失常发生的影响
Clin Med Insights Cardiol. 2016 Jul 26;10(Suppl 1):27-40. doi: 10.4137/CMC.S39708. eCollection 2016.
2
Major Persistent 5' Terminally Deleted Coxsackievirus B3 Populations in Human Endomyocardial Tissues.人类心内膜组织中主要的持续性5'末端缺失柯萨奇病毒B3群体
Emerg Infect Dis. 2016 Aug;22(8):1488-90. doi: 10.3201/eid2208.160186.
3
Suppression of Early and Late Afterdepolarizations by Heterozygous Knockout of the Na+/Ca2+ Exchanger in a Murine Model.
Circ Res. 2022 Jun 10;130(12):1926-1964. doi: 10.1161/CIRCRESAHA.122.320258. Epub 2022 Jun 9.
4
Oncolytic Virotherapy: From Bench to Bedside.溶瘤病毒疗法:从实验台到临床应用
Front Cell Dev Biol. 2021 Nov 26;9:790150. doi: 10.3389/fcell.2021.790150. eCollection 2021.
5
Extracellular SPARC increases cardiomyocyte contraction during health and disease.细胞外基质糖胺聚糖蛋白聚糖增加了健康和疾病状态中心肌细胞的收缩。
PLoS One. 2019 Apr 1;14(4):e0209534. doi: 10.1371/journal.pone.0209534. eCollection 2019.
在小鼠模型中通过钠/钙交换体杂合敲除抑制早期和延迟后去极化
Circ Arrhythm Electrophysiol. 2015 Oct;8(5):1210-8. doi: 10.1161/CIRCEP.115.002927. Epub 2015 Sep 3.
4
Intricacies of cardiac damage in coxsackievirus B3 infection: implications for therapy.柯萨奇病毒B3感染中心脏损伤的复杂性:对治疗的启示
Int J Cardiol. 2014 Dec 15;177(2):330-339. doi: 10.1016/j.ijcard.2014.09.136. Epub 2014 Oct 18.
5
Coxsackievirus B3 modulates cardiac ion channels.柯萨奇病毒 B3 调节心脏离子通道。
FASEB J. 2013 Oct;27(10):4108-21. doi: 10.1096/fj.13-230193. Epub 2013 Jun 27.
6
New insights into the beneficial electrophysiologic profile of ranolazine in heart failure: prevention of ventricular fibrillation with increased postrepolarization refractoriness and without drug-induced proarrhythmia.深入了解雷诺嗪对心力衰竭有益的电生理特性:增加复极后不应期,预防心室颤动,而不会引起药物致心律失常。
J Card Fail. 2012 Dec;18(12):939-49. doi: 10.1016/j.cardfail.2012.10.017.
7
Cardiac electrophysiology in mice: a matter of size.小鼠心脏电生理学:大小问题。
Front Physiol. 2012 Sep 5;3:345. doi: 10.3389/fphys.2012.00345. eCollection 2012.
8
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.《2012年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南》:欧洲心脏病学会2012年急性和慢性心力衰竭诊断与治疗特别工作组编著。与欧洲心脏病学会心力衰竭协会(HFA)合作制定。
Eur Heart J. 2012 Jul;33(14):1787-847. doi: 10.1093/eurheartj/ehs104. Epub 2012 May 19.
9
Proarrhythmia in a non-failing murine model of cardiac-specific Na+/Ca 2+ exchanger overexpression: whole heart and cellular mechanisms.心脏特异性钠钙交换体过表达非衰竭型小鼠模型中的致心律失常作用:整体心脏和细胞机制。
Basic Res Cardiol. 2012 Mar;107(2):247. doi: 10.1007/s00395-012-0247-7. Epub 2012 Feb 11.
10
Electrophysiologic profile of dronedarone on the ventricular level: beneficial effect on postrepolarization refractoriness in the presence of rapid phase 3 repolarization.多非利特对心室水平电生理特性的影响:在快速相 3 复极存在时对复极后不应期的有益作用。
J Cardiovasc Pharmacol. 2012 Jan;59(1):92-100. doi: 10.1097/FJC.0b013e3182377a11.